Filing Flows › Quest Diagnostics (DGX) › Q2 2026
Quest Diagnostics (DGX) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 23, 2026
Quest Diagnostics (DGX) reported revenue of $3.0B for the second quarter 2026 (Q2 2026), +10% from a year earlier and +5% from the quarter before. Operating margin was 15.1%, net earnings $320M (10.5% of revenue).
Quest Diagnostics, Q2 2026: revenue $3.0B (+10% year over year), operating margin 15.1%, net earnings $320M, operating cash flow $597M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.0B | +5% | +10% |
| Operating profit | $459M | +15% | +5% |
| Net earnings | $320M | +27% | +13% |
| Operating cash flow | $597M | +115% | +10% |
| Free cash flow | $459M | +180% | +5% |
What changed
Revenue was $3.0B in Q2 2026, up 10% year over year and up 5% from the previous quarter. DIS business was the largest line at 98% of revenue. DIS business added $0.28B year over year (up 10%), 99% of the total change.
Operating profit was $0.46B, a 15.1% margin (down 0.8 points year over year). Of the extra revenue versus Q2 2025, 7% reached operating profit, below the 16% margin then. Total costs grew 11% against revenue growth of 10%. The fastest-growing cost line was Other operating costs (+105%). Net earnings were $0.32B, up 13% year over year. The effective tax rate was 20.9%.
Operating cash flow was $0.60B (up 10% year over year), 179% of net income including minority interests. Non-cash charges added back $0.15B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items added $0.09B. Capital expenditures of $0.14B left free cash flow of $0.46B.
Questions
What was Quest Diagnostics' revenue in the second quarter 2026?
Quest Diagnostics (DGX) reported revenue of $3.0B for the second quarter 2026 (Q2 2026), +10% from a year earlier and +5% from the quarter before.
Was Quest Diagnostics profitable in the second quarter 2026?
Operating profit was $459M (15.1% of revenue) and net earnings $320M.
Source: Quest Diagnostics 10-Q on SEC EDGAR.